BioVie Inc [BIVI] stock prices are up 6.24% to $0.50 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BIVI shares have gain 0.83% over the last week, with a monthly amount drifted -25.24%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 11, March 2024, BioVie Announces Pipeline Update and Near-Term Clinical Priorities. In a post published today on Yahoo Finance, Recently completed financing provides sufficient funds for near-term Parkinson’s Disease priority.
From an analyst’s perspective:
BioVie Inc [NASDAQ: BIVI] stock has seen the most recent analyst activity on July 22, 2022, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $7. Previously, B. Riley Securities started tracking the stock with Buy rating on January 15, 2021, and set its price target to $47.
The stock price of BioVie Inc [BIVI] has been fluctuating between $0.44 and $8.69 over the past year. BioVie Inc [NASDAQ: BIVI] shares were valued at $0.50 at the most recent close of the market.
Analyzing the BIVI fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -2.02, Equity is -3.34 and Total Capital is -5.91. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4716 points at the first support level, and at 0.4478 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5137, and for the 2nd resistance point, it is at 0.5320.
BioVie Inc [BIVI] reported earnings per share of -$0.22 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.32/share, meaning a difference of $0.1 and a surprise factor of 31.20%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.29 per share as compared to estimates of -$0.31 per share, a difference of $0.02 representing a surprise of 6.50%.
Ratios To Look Out For
It’s worth pointing out that BioVie Inc [NASDAQ:BIVI]’s Current Ratio is 1.47. Further, the Quick Ratio stands at 1.47, while the Cash Ratio is 1.45.
Transactions by insiders
Recent insider trading involved GORLIN STEVE, Director, that happened on Dec 01 ’23 when 75680.0 shares were sold. President & CEO, DO CUONG V completed a deal on Nov 30 ’23 to buy 10000.0 shares. Meanwhile, Director GORLIN STEVE sold 8560.0 shares on Sep 05 ’23.
